DCGI gives emergency use authorisation to COVID-19 vaccine...
New Delhi [India], February 21 (ANI): Hyderabad-based pharmaceutical company Biological E on Monday received...
SEC recommends regular market approval to Covaxin, Covishield...
New Delhi [India], January 19 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee...
SEC recommends emergency use authorization of Covovax,...
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee...
Approval to Covaxin for children aged between 2-18 years...
New Delhi [India], October 12 (ANI): After the evaluation of data Covaxin is yet to get approval by the Drugs...
Zydus Cadila vaccine to be inoculated through applicator, not...
New Delhi [India], October 7 (ANI): Following the approval of the Zydus Cadila vaccine by the Drugs Controller...
Discussion on pricing of Zydus Cadila's COVID-19 vaccine...
New Delhi [India], September 14 (ANI): The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D...
Cipla seeks DCGI nod for import of Moderna's COVID-19...
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III...
DGCI approves emergency use of Zydus's Virafin in treating...
Zydus' Virafin gets emergency use approval for treating...
Shortage of Remdesivir doses in K'taka hospitals, DGCI to...
Zydus Cadila seeks DCGI nod for using its hepatitis drug for...
Copyright © aninews.in | All Rights Reserved.